Skip to main content

Analysts’ Opinions Are Mixed on These Materials Stocks: Lithium Americas Corp. (LAC) and Clearwater Paper (CLW)

Tipranks - Sat Feb 21, 6:12AM CST

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Lithium Americas Corp. (LACResearch Report) and Clearwater Paper (CLWResearch Report).

President's Day Sale - 70% Off

Lithium Americas Corp. (LAC)

Canaccord Genuity analyst Katie Lachapelle maintained a Hold rating on Lithium Americas Corp. today and set a price target of C$7.00. The company’s shares closed last Thursday at $4.61.

Lachapelle has an average return of 37.7% when recommending Lithium Americas Corp.. ;'>

According to TipRanks.com, Lachapelle is ranked #200 out of 12109 analysts.

The word on The Street in general, suggests a Hold analyst consensus rating for Lithium Americas Corp. with a $6.43 average price target, a 42.9% upside from current levels. In a report issued on February 9, TD Cowen also maintained a Hold rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

Clearwater Paper (CLW)

In a report released yesterday, Ryland Conrad from RBC Capital maintained a Buy rating on Clearwater Paper, with a price target of $23.00. The company’s shares closed last Thursday at $15.36.

According to TipRanks.com, Conrad is ranked #3744 out of 12109 analysts.

Clearwater Paper has an analyst consensus of Moderate Buy, with a price target consensus of $19.67, which is a 21.6% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $20.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.